Atara Biotherapeutics Says Carol Gallagher To Replace Ron Renaud As Chair Of The Board Of Directors

RTTNews | 877 dagar sedan
Atara Biotherapeutics Says Carol Gallagher To Replace Ron Renaud As Chair Of The Board Of Directors

(RTTNews) - Atara Biotherapeutics, Inc. (ATRA) announced Monday that Carol Gallagher will assume the role of Chair of the Board of Directors, replacing Ron Renaud, who is stepping down to focus on his new position as Managing Director at Bain Capital Life Sciences.

Gallagher is a venture partner in the life sciences practice of New Enterprise Associates and an experienced public company director. She has served as a Director at Atara since 2013 and as a member of both the Compensation and Nominating and Corporate Governance Committees.

Gallagher was formerly the President and CEO of Calistoga Pharmaceuticals and has held commercial and drug development roles within Eli Lilly, Amgen, Agouron, Pfizer and Biogen Idec.

Atara also announced that after four years of service, Roy Baynes, has decided to step down from Atara's Board of Directors to pursue other external opportunities following his retirement from Merck.

read more
Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD

Atara's Ebvallo Receives European Commission Approval For Adults And Children With EBV+ PTLD

Atara Biotherapeutics, Inc. (ATRA) and French healthcare company Pierre Fabre announced Monday that the European Commission (EC) has granted marketing authorization for Ebvallo (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.
RTTNews | 877 dagar sedan
E.ON Confirms Outlook After Higher Q1 Adj. Earnings

E.ON Confirms Outlook After Higher Q1 Adj. Earnings

German utility E.ON SE reported Wednesday a significant increase in its first-quarter adjusted earnings and Group EBITDA with growth in all three core segments. Further, the firm affirmed its guidance for 2025 and its outlook through 2028. On the XETRA in Germany, E.ON shares were gaining around 1.36 percent.
RTTNews | 5h 57minuter sedan
Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the European session on Wednesday.
RTTNews | 8h 21minuter sedan
FTSE 100 Flat As Stocks Move In Tight Range

FTSE 100 Flat As Stocks Move In Tight Range

U.K. stocks are mostly subdued in lackluster trade on Wednesday as investors react to a mixed batch of earnings announcements, and await more economic data from the U.S., and clarity about Trump administration's stance on tariffs with regard to European countries.
RTTNews | 8h 56minuter sedan
CAC 40 Down 0.66%; Bouygues Rises Sharply On Earnings

CAC 40 Down 0.66%; Bouygues Rises Sharply On Earnings

French stocks are exhibiting weakness on Wednesday, snapping a four-session winning streak, as investors focus on earnings and other corporate news, and await more economic data for directional clues. Some profit taking is also contributing to market's weakness.
RTTNews | 9h 17minuter sedan
Sensex, Nifty End Choppy Session Modestly Higher

Sensex, Nifty End Choppy Session Modestly Higher

Indian shares ended modestly higher on Wednesday as signs of easing retail inflation sparked hopes for more rate cuts from the Reserve Bank of India in coming months.
RTTNews | 9h 22minuter sedan